Rezina Arju

1.2k total citations
16 papers, 933 citations indexed

About

Rezina Arju is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rezina Arju has authored 16 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rezina Arju's work include PI3K/AKT/mTOR signaling in cancer (4 papers), CRISPR and Genetic Engineering (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Rezina Arju is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), CRISPR and Genetic Engineering (3 papers) and Cytokine Signaling Pathways and Interactions (2 papers). Rezina Arju collaborates with scholars based in United States, Brazil and Puerto Rico. Rezina Arju's co-authors include Robert J. Schneider, Tsivia Hochman, Judith D. Goldberg, Silvia C. Formenti, Shah Giashuddin, Deborah Silvera, Steve Braunstein, Ladan Zolfaghari, Joan Cangiarella and Paul H. Levine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Rezina Arju

16 papers receiving 929 citations

Peers

Rezina Arju

ONCOL

IMMUN

PHEOH

Rama Soundararajan United States

Andrew Trotta Australia

Oscar Gee‐Wan Wong Hong Kong

Zhijie Xiao China

Martina L. Skrede Norway

Anna-Karin Sjögren Sweden

Zhiming Zhang China

Laudine Communal Canada

Lisa Gangi United States

Lilach Kleinberg Norway

Rama Soundararajan United States

Rezina Arju

403 ×0.7

263 ×1.0

ONCOL

242 ×1.4

135 ×1.0

IMMUN

42 ×0.4

PHEOH

Citations per year, relative to Rezina Arju Rezina Arju (= 1×) peers Rama Soundararajan

Countries citing papers authored by Rezina Arju

Since Specialization

Citations

This map shows the geographic impact of Rezina Arju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rezina Arju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rezina Arju more than expected).

Fields of papers citing papers by Rezina Arju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rezina Arju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rezina Arju. The network helps show where Rezina Arju may publish in the future.

Co-authorship network of co-authors of Rezina Arju

This figure shows the co-authorship network connecting the top 25 collaborators of Rezina Arju. A scholar is included among the top collaborators of Rezina Arju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rezina Arju. Rezina Arju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Gadi, Abhilash, Viviana Volta, Beth Walters, et al.. (2019). Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network. Cancer Research. 79(13). 3360–3371. 122 indexed citations

Ernlund, Amanda, Sofia Bakogianni, Amandine Alard, et al.. (2017). Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming. Genes & Development. 31(22). 2235–2249. 38 indexed citations

Goldman, Kara N., Devon Chenette, Rezina Arju, et al.. (2017). mTORC1/2 Inhibition Preserves Ovarian Function and Fertility During Genotoxic Chemotherapy. Obstetrical & Gynecological Survey. 72(7). 415–416. 2 indexed citations

Goldman, Kara N., Devon Chenette, Rezina Arju, et al.. (2017). mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proceedings of the National Academy of Sciences. 114(12). 3186–3191. 132 indexed citations

Kaur, Navneet, et al.. (2016). Primary Clear Cell Carcinoma of the Non-cirrhotic Liver Presenting as an Acute Abdomen: a Case Report and Review of the Literature. Journal of Gastrointestinal Cancer. 48(2). 211–216. 3 indexed citations

Arju, Rezina, et al.. (2016). Gastric siderosis: An under-recognized and rare clinical entity. SAGE Open Medicine. 4. 2103704109–2103704109. 15 indexed citations

Silvera, Deborah, Amanda Ernlund, Rezina Arju, et al.. (2016). mTORC1 and -2 Coordinate Transcriptional and Translational Reprogramming in Resistance to DNA Damage and Replicative Stress in Breast Cancer Cells. Molecular and Cellular Biology. 37(5). 32 indexed citations

Suárez-Arroyo, Ivette J., Rezina Arju, Shah Giashuddin, et al.. (2016). The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.. PubMed. 6(8). 1720–40. 27 indexed citations

Jhaveri, Komal, Eleonora Teplinsky, Deborah Silvera, et al.. (2015). Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy. Clinical Breast Cancer. 16(2). 113–122.e1. 50 indexed citations

10.

Arju, Rezina, et al.. (2015). Metastatic Colonic Adenocarcinoma in Breast: Report of Two Cases and Review of the Literature. SHILAP Revista de lepidopterología. 2015. 1–6. 6 indexed citations

11.

Arju, Rezina, et al.. (2014). Jorge Lobo’s disease: a case of keloidal blastomycosis (lobomycosis) in a nonendemic area. Therapeutic Advances in Infectious Disease. 2(3-4). 91–96. 6 indexed citations

12.

Teplinsky, Eleonora, Rezina Arju, Shah Giashuddin, et al.. (2013). Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).. Journal of Clinical Oncology. 31(26_suppl). 60–60. 1 indexed citations

13.

Arslan, Alan A., Deborah Silvera, Rezina Arju, et al.. (2012). Atypical ezrin localization as a marker of locally advanced breast cancer. Breast Cancer Research and Treatment. 134(3). 981–988. 19 indexed citations

14.

Simpson, Natalie E., W. Marcus Lambert, Shah Giashuddin, et al.. (2010). High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance. Cancer Research. 70(21). 8446–8456. 48 indexed citations

15.

Silvera, Deborah, Rezina Arju, Farbod Darvishian, et al.. (2009). Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nature Cell Biology. 11(7). 903–908. 192 indexed citations

16.

Braunstein, Steve, Carolina Pola, Judith D. Goldberg, et al.. (2007). A Hypoxia-Controlled Cap-Dependent to Cap-Independent Translation Switch in Breast Cancer. Molecular Cell. 28(3). 501–512. 240 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact